Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Radium Ra 223 dichloride |
Synonyms | |
Therapy Description |
Radium Ra 223 dichloride is a radium-based radiopharmaceutical that targets bone via incorporation into bony matrix, and results in DNA double strand breaks and tumor regression in bone (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Radium Ra 223 dichloride | Xofigo | BAY 88-8223|alpharadin|BAY88-8223|Radium 223 Dichloride | Radium Ra 223 dichloride is a radium-based radiopharmaceutical that targets bone via incorporation into bony matrix, and results in DNA double strand breaks and tumor regression in bone (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02463799 | Phase II | Radium Ra 223 dichloride Sipuleucel-T | Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC | Completed | USA | 0 |
NCT06401980 | Phase II | Docetaxel Radium Ra 223 dichloride 177Lu-rhPSMA-10.1 Darolutamide Olaparib Cabazitaxel | Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Recruiting | CHE | 0 |
NCT02406521 | Phase I | Pazopanib Radium Ra 223 dichloride Sorafenib | Exploratory Study of Radium-223 and Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Metastases | Completed | USA | 0 |
NCT02396368 | Phase I | Tasquinimod Radium Ra 223 dichloride | A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer | Withdrawn | USA | 0 |
NCT02034552 | Phase II | Prednisone Radium Ra 223 dichloride Enzalutamide Abiraterone | A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) | Completed | USA | 0 |
NCT02258451 | Phase II | Everolimus + Exemestane Radium Ra 223 dichloride | Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer | Completed | USA | POL | NOR | ITA | ISR | GBR | FRA | ESP | DEU | CHE | BEL | AUT | 5 |
NCT04071236 | Phase Ib/II | Peposertib + Radium Ra 223 dichloride Radium Ra 223 dichloride Avelumab + Peposertib + Radium Ra 223 dichloride | Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy | Recruiting | USA | 0 |
NCT03093428 | Phase II | Pembrolizumab + Radium Ra 223 dichloride Radium Ra 223 dichloride | Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC | Active, not recruiting | USA | 0 |
NCT02258464 | Phase II | Radium Ra 223 dichloride | Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer | Terminated | USA | POL | NOR | NLD | ISR | IRL | GBR | FRA | FIN | ESP | DNK | DEU | CZE | CHE | CAN | AUT | 4 |
NCT02507570 | Phase II | Enzalutamide Radium Ra 223 dichloride | Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis | Completed | USA | 0 |
NCT02605356 | Phase Ib/II | Radium Ra 223 dichloride Bortezomib Dexamethasone | Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma | Withdrawn | USA | ITA | ISR | GRC | ESP | DEU | CAN | BEL | AUS | 2 |
NCT02043678 | Phase III | Prednisone Abiraterone Radium Ra 223 dichloride | Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms | Completed | USA | SWE | POL | NOR | NLD | ITA | ISR | GBR | FRA | FIN | ESP | DEU | CAN | BRA | BEL | AUS | 3 |